Pastāsti draugiem par šo preci:
Pharmacokinetics in Drug Development: Clinical Study Design and Analysis (Volume 1) Peter L Bonate 2004 edition
Pharmacokinetics in Drug Development: Clinical Study Design and Analysis (Volume 1)
Peter L Bonate
These volumes are designed to be the most complete guide to pharmacokinetics (PK) and its role in drug development. Volume 2 details the key regulatory and development paradigms in which PK supplements decision-making during drug development.
Marc Notes: Includes bibliographical references and index. Table of Contents: First-Time-in-Man Studies.- Drug-Drug Interactions.- Food Effect Studies.- Bioavailability and Bioequivalence Studies.- Mass Balance Studies.- Design, Conduct, and Analysis of Studies in Patients with Hepatic Impairment.- Design, Conduct, and Analysis of Studies in Patients with Renal Impairment.- Special Populations.- Non-compartmental Analysis.- Analysis of Urine Excretion Data.- Compartmental Models.- The Role of Metabolite Pharmacokinetics and Pharmacodynamics in Drug Development.- Average, Population, and Individual Bioequivalence.- Assessment of Dose Proportionality.- Analysis of Absorption Kinetic Data.- Interspecies Pharmacokinetic Scaling: Principles, Applications, and Limitations.- In Vitro Drug Metabolism Information in the Prediction of Human Pharmacokinetics.- Practical Deconvolution.- Population Pharmacokinetics: Applications in Industry.- Clinical Trial Simulation.- The Strategic Role and Application of Pharmacokinetic/Pharmacodynamic Modeling in Drug Development.- The Analysis of Clincal Safety Data in Phase I-II Pharmacokinetic Studies.
| Mediji | Grāmatas Hardcover Book (Grāmata ar cieto muguriņu un vāku) |
| Izlaists | 2005. gada 5. decembris |
| ISBN13 | 9780971176744 |
| Izdevēji | AAPS Press |
| Lapas | 628 |
| Izmēri | 178 × 254 × 34 mm · 1,32 kg |
| Valoda | Angļu |
| Redaktors | Bonate, Peter L. |
| Redaktors | Howard, Danny R. |